最新日韩中文字幕,av男人网

BenzenEPEntanoicacid, a-amino-, (aR)-;
BenzenEPEntanoicacid, a-amino-, (R)-;
(R)-2-Amino-5-phenylpentanoic acid;
(R)-a-AminobenzenEPEntanoicacid;
D-2-Amino-5-phenylvaleric acid

C11H15NO2

詳情

供應商

21699-53-6

Cyclopenta[c]pyran-1-ol,octahydro-4,7-dimethyl-, (1R,4S,4aR,7S,7aR)-;
Cyclopenta[c]pyran-1-ol,1a,3,4,4aa,5,6,7,7aa-octahydro-4b,7a-dimethyl-, (-)- (8CI);
Cyclopenta[c]pyran-1-ol,octahydro-4,7-dimethyl-, [1R-(1a,4b,4aa,7a,7aa)]-;
(-)-Neomatatabiol;
(1R,4S,4aR,7S,7aR)-DihydronEPEtalactol;
Neomatatabiol;
Neomatatabiol, (-)-

Lup-20(29)-en-3-ol, (3b,18b,19b)- (9CI);
1H-Cyclopenta[a]chrysene,lup-20(29)-en-3-ol deriv.;
(+)-NEPEhinol;
NEPEhinol

Manganese,pentacarbonyl(trifluoroacetyl)-, (OC-6-21)- (9CI);
(Trifluoroacetyl)manganesEPEntacarbonyl (6CI);
Manganese, pentacarbonyl(trifluoroacetyl)- (7CI,8CI);
Acetaldehyde, trifluoro-, manganese complex;
NSC 160484;
Perfluoroacetylmanganese pentacarbonyl

Piperidinium,3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1,1-dimethyl-, (3R)-;
Piperidinium,3-[(hydroxydiphenylacetyl)oxy]-1,1-dimethyl-, (3R)- (9CI);
Piperidinium, 3-[(hydroxydiphenylacetyl)oxy]-1,1-dimethyl-,(R)-;
(R)-MEPEnzolate

1(2H)-PyrimidinEPEntanoicacid, 3,4-dihydro-2,4-dioxo-;
1(2H)-Pyrimidinevalericacid, 3,4-dihydro-2,4-dioxo- (7CI,8CI);
NSC 83960

1(4H)-PyridinEPEntanoicacid, 3,5-diiodo-4-oxo-;
1(4H)-Pyridinevalericacid, 3,5-diiodo-4-oxo- (8CI)

1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, (2S)-;
1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, (S)-;
(+)-EPErisone;
(S)-EPErisone

1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, (2R)-;
1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, (R)-;
(-)-EPErisone;
(R)-EPErisone

1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, hydrochloride (1:1), (2R)-;
1-Propanone,1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, hydrochloride, (2R)- (9CI);
(-)-EPErisone hydrochloride;
(R)-EPErisone hydrochloride

2(3H)-Furanone,4-[bis(3,4,5-trimethoxyphenyl)methyl]dihydro-3-methyl-, (3S,4S)-;
2(3H)-Furanone,4-[bis(3,4,5-trimethoxyphenyl)methyl]dihydro-3-methyl-, (3S-trans)-;
(+)-PEPEromin C;
PEPEromin C

30-Norlupan-20-one,1,3,11-trihydroxy-, (1b,3b,11a)- (9CI);
1H-Cyclopenta[a]chrysene,30-norlupan-20-one deriv.;
(-)-NEPEtidone;
NEPEtidone

(S)-瑞格列奈乙基酯

(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl);
(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl);
(+)-2-ETHOXY-4-(N-3-METHYL-1(S)-(2-(1-PEPERIDINYL)PHENYL)-BUTYL)CARBAMOYLMETHYL) BENZOIC ACID;
(S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate;
(S)-Repaglinide Ethyl Ether (Repaglinide Impurity);
2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid Ethyl Ester;
(S)-Repaglinide Ethyl Ester (Repaglinide Impurity)

(+/-)11,12-EPOXYEICOSA-5Z,8Z,14Z-TRIENOIC ACID;
(+/-)11,12-EET;
11,12-EET;
(+/-)11(12)-EPETRE;
11(12)-EPETRE;
(+/-)11(12)-EPOXY-5Z,8Z,14Z-EICOSATRIENOIC ACID;
11,12-EPOXY-(5Z,8Z,14Z)-EICOSATRIENOIC ACID;
(+/-)11,12-EPOXYEICOSA-5Z,8Z,14Z-TRIENOIC ACID;
11,12-epoxy-5,8,14-eicosatrienoicacid

(+/-)14,15-EPOXYEICOSA-5Z,8Z,11Z-TRIENOIC ACID;
(+/-)14,15-EPOXYEICOSA-5Z,8Z,11Z-TRIENOIC ACID;
(+/-)14,15-EET;
14,15-EET;
(+/-)14(15)-EPETRE;
14(15)-EPETRE;
(+/-)14(15)-EPOXY-5Z,8Z,11Z-EICOSATRIENOIC ACID;
14,15-epoxy-5,8,11-eicosatrienoicacid;
(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

Fluvoxamine Acid;
(E)-d-[(2-Aminoethoxy)imino]-4-(trifluoromethyl)benzenEPEntanoic Acid;
Fluvoxamine Acid

(2R,3R,4R,5R)-1,2,3,4,5-NonadecanEPEntol 3-Methanesulfonate;
(2R,3R,4R,5R)-1,2,3,4,5-NonadecanEPEntol 3-Methanesulfonate;
(2R,3R,4R,5R)-

C20H42O7S

詳情

供應商

化工產品